Health Care Counsel Blog
856 total results. Page 18 of 35.
Lawmakers remain in negotiations among the three key committees in the House of Representatives: Energy & Commerce, Ways & Means, and Education & Labor, along with the Senate Committee on Health, Education, Labor and Pensions (HELP), about the best way to address surprise medical bills.
In March 2020, Health Care Partner Anne Murphy published an article in AHLA Weekly on compliance considerations when closing a hospital.
The Centers for Medicare and Medicaid Services (CMS) issued a second Healthcare Common Procedure Coding System (HCPCS) code to be used by laboratories for the testing and tracking of new cases of the 2019-Novel Coronavirus disease (COVID-19).
CMS published the Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly Proposed Rule (the Proposed Rule).
Headlines that Matter for Companies and Executives in Regulated Industries
The Centers for Medicare and Medicaid Services announced in two letters to State Survey Agencies new guidance for infection control and prevention concerning coronavirus 2019.
The Centers for Medicare and Medicaid Services (CMS) is suspending non-emergency inspections in order to allow inspectors to focus on the most serious health and safety threats.
Health Care Partner Stephanie Trunk will present at CBI’s 2020 PAP Conference.
Headlines that Matter for Companies and Executives in Regulated Industries
Check out the analysis by Protenus, a health care compliance analytics firm.
Headlines that Matter for Companies and Executives in Regulated Industries
On Tuesday, February 11, 2020, the Equal Employment Opportunity Commission filed a complaint against Yale New Haven Hospital.
Headlines that Matter for Companies and Executives in Regulated Industries
On February 12, 2020, the New York State Department of Health (DOH) issued a Dear Administrator Letter clarifying DOH’s policies for hospice patients residing in adult care facilities (ACF) when those ACF Hospice Residents are no longer capable of self-administration of medications.
On February 5, 2020, the Centers for Medicare and Medicaid Services (CMS) proposed removing long-standing prohibitions and eligibility restrictions that had barred many individuals with End-Stage Renal Disease (ESRD) from participating in the Medicare Advantage program.
Headlines that Matter for Companies and Executives in Regulated Industries
A software developer of an electronic health records system utilizing AI is the recent target in a DOJ fraud investigation.
Spurred by physician sexual misconduct and abuse at high-profile institutions, California now requires clinics, health facilities, and “other entities” to report certain written allegations of a health care professional’s sexual misconduct to the professional’s licensing agency.
Headlines that Matter for Companies and Executives in Regulated Industries
The health care industry continues to be a top priority of the Justice Department with respect to False Claims Act enforcement. In the meantime, investment in a robust compliance program may pay off in cooperation credits to mitigate a False Claims violation.
The Oregon Department of Consumer and Business Services (the Department) issued a proposed bulletin on January 26 that seeks to provide guidance to drug manufacturers regarding the Department’s interpretation of what constitutes a “new prescription drug” for purposes of price reporting.
Headlines that Matter for Companies and Executives in Regulated Industries
The federal government revealed in a recent report that of the $3 billion it recovered last year from companies charged with fraud and abuse, more than $2.6 billion involved the health care industry, marking the tenth consecutive year that the Department of Justice recovered more than $2 billion fro
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries